Neurological disorders in pregnancy from a neuroimaging perspective

Seminars in Neurology

Volumn 27, Issue 5, 2007, Pages 411-424

  Brass, Steven David ^a   Copen, William A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Brain tumor; Choriocarcinoma; Cortical venous thrombosis; Eclampsia; Pregnancy; Stroke

Indexed keywords

BACKACHE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; CHORIOCARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; ECLAMPSIA; FETUS RISK; HUMAN; HYPOPHYSIS APOPLEXY; HYPOPHYSITIS; MENINGIOMA; MULTIPLE SCLEROSIS; NEUROIMAGING; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PUERPERIUM; REVIEW; WERNICKE ENCEPHALOPATHY;

DIAGNOSTIC IMAGING; FEMALE; HUMANS; NERVOUS SYSTEM DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 35649023097     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-991123     Document Type: Review

References (106)

1. Wagner LK, Lester RG, Saldana LR. Exposure of the Pregnant Patient to Diagnostic Radiations: A Guide to Medical Management. Philadelphia: Lippincott; 1985:19-223
2. Berlin L. Radiation exposure and the pregnant patient. AJR Am J Roentgenol 1996;167:1377-1379
3. Damilakis J, Prassopoulos P, Perisinakis K, Faflia C, Gourtsoyiannis N. CT of the sacroiliac joints: Dosimetry and optimal settings for a high-resolution technique. Acta Radiol 1997;38:870-875
4. Damilakis J, Perisinakis K, Voloudaki A, Gourtsoyiannis N. Estimation of fetal radiation dose from computed tomography scanning in late pregnancy: depth-dose data from routine examinations. Invest Radiol 2000;35:527-533
5. Wagner LK, Archer BR, Zeck OF. Conceptus dose from two state-of-the-art CT scanners. Radiology 1986;159:787-792
6. Mole RH. Irradiation of the embryo and fetus. Br J Radiol 1987;60:17-31
7. Giles D, Hewitt D, Stewart A, Webb J. Malignant disease in childhood and diagnostic irradiation in utero. Lancet 1956;271:447
8. Roberts PJ, Given-Wilson R, Gifford D, Bryan G. Pregnancy and Work in Diagnostic Imaging. Report of a Joint Working Party of the Royal College of Radiologists and British Institute of Radiology. London: British Institute of Radiology; 1992
9. Mole RH. Childhood cancer after prenatal exposure to diagnostic x-ray examinations in Britain. Br J Cancer 1990; 62:152-168
10. United Nations Scientific Committee on the Effects of Atomic Radiation. Ionizing Radiation: Levels and Effects. 1972 Report to the General Assembly, with annexes. Vol. II: Effects. New York, NY: United Nations; 1972
11. Muirhead CR, Cox R, Stather JW, et al. Estimates of Late Radiation Risks to the UK Population. Documents of the NRPB 4[4]. Chilton: National Radiological Protection Board; 1993:15-157
12. Ginsberg JS, Hirsh J, Rainbow AJ, Coates G. Risks to the fetus of radiologic procedures used in the diagnosis of maternal venous thromboembolic disease. Thromb Haemost 1989;61:189-196
13. Doll R, Wakeford R. Risk of childhood cancer from fetal irradiation. Br J Radiol 1997;70:130-139
14. Gilman EA, Kneale GW, Knox EG, Stewart AM. Pregnancy x-rays and childhood cancers: effects of exposure age and radiation dose. J Radiol Prot 1988;8:3-8
15. Benjamin SA, Lee AC, Angleton GM, et al. Neoplasms in young dogs after perinatal irradiation. J Natl Cancer Inst 1986;77:563-571
16. Idaho State University. Radiation and risk. Available at: http:www.physics.isu.eduradinfrisk.htm. Accessed December 10, 2006
17. ACOG Committee on Obstetric Practice. ACOG Committee Opinion Number 299, September 2004. Guidelines for diagnostic imaging during pregnancy. Obstet Gynecol 2004;104:647-651
18. Nelson JA, Livingston JC, Moon RG. Mutagenic evaluation of radiographic contrast media. Invest Radiol 1982; 17:183-185
19. Morisetti A, Tirone P, Luzzani F, de Haen C. Toxicologic safety assessment of iomeprol, a new x-ray contrast agent. Eur J Radiol 1994;18(suppl 1):S21-S31
20. Ralston WH, Robbins MS, James P. Reproductive, developmental, and genetic toxicity of ioversol. Invest Radiol 1989;24(suppl 1):S16-S22
21. Rodesch F, Camus M, Ermans AM, Dodion J, Delange F. Adverse effects of amniofetography on fetal thyroid function. Am J Obstet Gynecol 1976;126:723-726
22. Bona G, Zaffaroni M, Defilippi C, Gallina MR, Mostert M. Effects of iopamidol on neonatal thyroid function. Eur J Radiol 1992;14:22-25
23. Webb JA, Thomsen HS, Morcos SK, Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol 2005;15:1234-1240
24. Russell LB, Russell WL. An analysis of the changing radiation response of the developing mouse embryo. J Cell Physiol 1954;43(suppl 1):130-149
25. Brent RL, Gorson RO. Radiation exposure in pregnancy. In: Moseley RD Jr., et al, eds. Current Problems in Radiology. Vol. 2. Chicago, IL: Year Book Medical Publishers Inc; 1972:1-48
26. Blot WJ, Miller RW. Mental retardation following in utero exposure to the atomic bombs of Hiroshima and Nagasaki. Radiology 1973;106:617-619
27. Yamazaki JN, Schull WJ. Perinatal loss and neurological abnormalities among children of the atomic bomb: Nagasaki and Hiroshima revisited, 1949 to 1989. JAMA 1990;264: 605-609
28. Otake M, Schull WJ. In utero exposure to A-bomb radiation and mental retardation: a reassessment. Br J Radiol 1984; 57:409-414
29. Dekaban AS. Abnormalities in children exposed to x-radiation during various stages of gestation: tentative timetable of radiation to the human fetus. J Nucl Med 1968;9:471-477
30. Stewart A, Kneale GW. Radiation dose effects in relation to obstetric x-rays and childhood cancers. Lancet 1970;1:1185-1188
31. Wakeford R, Little MP. Risk coefficients for childhood cancer after intrauterine irradiation: a review. Int J Radiat Biol 2003;79:293-309
32. Hall EJ, Giaccia AJ. Radiobiology for the Radiologist. Philadelphia: Lippincott Williams & Wilkins; 2006
33. Omnipaque [package insert]. Available at: http://www. amershamhealth-us.com/shared/pdfs/pi/Omnipaque.pdf. Accessed December 18, 2006
34. Heinrichs WL, Fong P, Flannery M, et al. Midgestational exposure of pregnant BALB/c mice to magnetic resonance imaging conditions. Magn Reson Imaging 1988;6:305-313
35. Tyndall DA, Sulik KK. Effects of magnetic resonance imaging on eye development in the C57BL/6J mouse. Teratology 1991;43:263-275
36. Yip YP, Capriotti C, Talagala SL, Yip JW. Effects of MR exposure at 1.5T on early embryonic development of the chick. J Magn Reson Imaging 1994;4:742-748
37. Kanal E, Shellock FG, Talagala L. Safety considerations in MR imaging. Radiology 1990;176:593-606
38. National Radiological Protection Board. Principles for the Protection of Patients and Volunteers during Clinical Magnetic Resonance Diagnostic Procedures. Documents of the NRPB. Vol. 2, No. 1. London: HM Stationery Office; 1991
39. Shellock FG, Kanal E. Policies, guidelines, and recommendations for MR imaging safety and patient management. J Magn Reson Imaging 1991;1:97-101
40. Baker PN, Johnson IR, Harvey PR, Gowland PA, Mansfield P. A three-year follow-up of children imaged in utero with echo-planar magnetic resonance. Am J Obstet Gynecol 1994; 170:32-33
41. Glover P, Hykin J, Gowland P, Wright J, Johnson I, Mansfield P. An assessment of the intrauterine sound intensity level during obstetric echo-planar magnetic resonance imaging. Br J Radiol 1995;68:1090-1094
42. Omniscan [package insert]. Available at: http://www.amershamhealth-us. com/shared/pdfs/pi/omniscan.pdf. Accessed September 22, 2007
43. Magnevist [package insert]. Available at: http://www.fda.gov/medwatch/ SAFETY/2005/Jan_PI/Magnevist_PI.pdf. Accessed December 18, 2006
44. Kittner SJ, Stern BJ, Feeser BR, et al. Pregnancy and the risk of stroke. N Engl J Med 1996;335:768-774
45. Wilterdink JL, Easton JD. Cerebral ischemia in pregnancy. Adv Neurol 2002;90:51-62
46. Wilterdink JL, Feldmann E. Intracranial hemorrhage. Adv Neurol 2002;90:63-74
47. Xavier AR, Qureshi AI, Kirmani JF, Yahia AM, Bakshi R. Neuroimaging of stroke: a review. South Med J 2003;96: 367-379
48. Grant PE, He J, Halpern EF, et al. Frequency and clinical context of decreased apparent diffusion coefficient reversal in the human brain. Radiology 2001;221:43-50
49. Grossman RI, Yousem DM, eds. The Requisites: Neuroradiology. 2nd ed. Philadelphia: Elsevier; 2003:173-241
50. Brant-Zawadzki M, Atkinson D, Detrick M, Bradley WG, Scidmore G. Fluid-attenuated inversion recovery (FLAIR) for assessment of cerebral infarction. Initial clinical experience in 50 patients. Stroke 1996;27:1187-1191
51. Lovblad KO, Laubach HJ, Baird AE, et al. Clinical experience with diffusion-weighted MR in patients with acute stroke. AJNR Am J Neuroradiol 1998;19:1061-1066
52. Singer MB, Chong J, Lu D, et al. Diffusion-weighted MRI in acute subcortical infarction. Stroke 1998;29:133-136
53. van Everdingen KJ, van der Grond J, Kappelle LJ, et al. Diffusion-weighted magnetic resonance imaging in acute stroke. Stroke 1998;29:1783-1790
54. Perkins CJ, Kahya E, Roque CT, Roche PE, Newman GC. Fluid-attenuated inversion recovery and diffusion- and perfusion-weighted MRI abnormalities in 117 consecutive patients with stroke symptoms. Stroke 2001;32:2774-2781
55. Gonzalez RG, Schaefer PW, Buonanno FS, et al. Diffusion-weighted MR imaging: diagnostic accuracy in patients imaged within 6 hours of stroke symptom onset. Radiology 1999;210:155-162
56. Urbach H, Flacke S, Keller E, et al. Detectability and detection rate of acute cerebral hemisphere infarcts on CT and diffusion-weighted MRI. Neuroradiology 2000;42:722-727
57. Fiebach JB, Schellinger PD, Jansen O, et al. CT and diffusion-weighted MR imaging in randomized order: diffusion-weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke. Stroke 2002;33:2206-2210
58. Mullins ME, Schaefer PW, Sorensen AG, et al. CT and conventional and diffusion-weighted MR imaging in acute stroke: study in 691 patients at presentation to the emergency department. Radiology 2002;224:353-360
59. Manzione J, Newman GC, Shapiro A, Santo-Ocampo R. Diffusion- and perfusion- weighted MR imaging of dural sinus thrombosis. AJNR Am J Neuroradiol 2000;21:68-73
60. Ducreux D, Oppwnheim C, Vandamme X, et al. Diffusion-weighted imaging patterns of brain damage associated cerebral venous thrombosis. AJNR Am J Neuroradiol 2001; 22:261-268
61. Mullins ME, Grant PE, Wang B, Gonzalez RG, Schaeffer PW. Parenchymal abnormalities associated with cerebral venous sinus thrombosis: assessment with diffusion-weighted MR imaging. AJNR Am J Neuroradiol 2004;25:1666-1675
62. Bateman BT, Schumacher HC, Bushnell CD, et al. Intracerebral hemorrhage in pregnancy: frequency, risk factors, and outcome. Neurology 2006;67:424-429
63. Witlin AG, Friedman SA, Egerman RS, Frangieh AY, Sibai BM. Cerebrovascular disorders complicating pregnancy: beyond eclampsia. Am J Obstet Gynecol 1997;176: 1139-1148
64. Moodley J, Kalane G. A review of the management of eclampsia: practical issues. Hypertens Pregnancy 2006;25: 47-62
65. Koch S, Rabinstein A, Falcone S, Forteza A. Diffusion-weighted imaging shows cytotoxic and vasogenic edema in eclampsia. AJNR Am J Neuroradiol 2001;22:1068-1070
66. Loureiro R, Leite CC, Kahhale S, et al. Diffusion imaging may predict reversible brain lesions in eclampsia and severe pre-eclampsia: initial experience. Am J Obstet Gynecol 2003;189:1350-1355
67. Finocchi V, Bozzao A, Bonamini M, et al. Magnetic resonance imaging in posterior reversible encephalopathy syndrome: report of three cases and review of literature. Arch Gynecol Obstet 2005;271:79-85
68. Shah AK, Whitty JE. Brain MRI in peripartum seizures: usefulness of combined T2 and diffusion weighted MR imaging. J Neurol Sci 1999;166:122-125
69. Provenzale JM, Petrella JR, Cruz LCH, Wong JC, Engelter S, Barboriak DP. Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2001;22:1455-1461
70. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukencephalopathy syndrome. N Engl J Med 1996;334:494-500
71. Covarrubias DJ, Luetmer PH, Campeau NG. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 2002;23:1038-1048
72. Schaefer PW, Buonanno FS, Gonzalez RG, Schwamm LH. Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 1997;28:1082-1085
73. Ay H, Buonanno FS, Schaefer PW, et al. Posterior leukencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology 1998;51:1369-1376
74. Geijer B, Sundgren PC, Lindgren A, Brockstedt S, Stahlberg F, Holtas S. The value of b required to avoid T2 shine-through from old lacunar infarcts in diffusion-weighted imaging. Neuroradiology 2001;43:511-517
75. D'Aprile P, Farchi G, Pagliarulo R, Carella A. Thrombotic thrombocytopenic purpura: MR demonstration of reversible brain abnormalities. AJNR Am J Neuroradiol 1994;15:19-20
76. Singhal AB. Postpartum angiopathy with reversible posterior leukoencephalopathy. Arch Neurol 2004;61:411-416
77. Neudecker S, Stock K, Krasnianski M. Call-Fleming postpartum angiopathy in the puerperium: a reversible cerebral vasoconstriction syndrome. Obstet Gynecol 2006; 107:446-449
78. Call GK, Fleming MC, Sealfon S, Levine H, Kistler JP, Fisher CM. Reversible cerebral segmental vasoconstriction. Stroke 1988;19:1159-1170
79. Singhal AB, Caviness VS, Begleiter AF, Mark EJ, Rordorf G, Koroshetz WJ. Cerebral vasoconstriction and stroke after use of serotonergic drugs. Neurology 2002;58:130-133
80. Ruggenenti P, Remuzzi G. The pathophysiology and management of thrombotic thrombocytopenic purpura. Eur J Haematol 1996;56:191-207
81. Bakshi R, Shaikh ZA, Bates VE, Kinkel PR. Thrombotic thrombocytopenic purpura: Brain CT and MRI findings in 12 patients. Neurology 1999;52:1285-1288
82. Kanaan I, Jallu A, Kanaan H. Management strategy for meningioma in pregnancy: a clinical study. Skull Base 2003; 13:197-203
83. Mamelak AN, Withers GJ, Wang X. Choriocarcinoma brain metastasis in a patient with viable intrauterine pregnancy. J Neurosurg 2002;97:477-481
84. Biousse V, Newman NJ, Oyaizu NM. Precipitating factors in pituitary apoplexy. J Neurol Neurosurg Psychiatry 2001; 71:542-545
85. Masding MG, Lees PD, Gawne-Cain ML, Sandeman DD. Visual field compression by a non-secreting pituitary tumour during pregnancy. J R Soc Med 2003;96:27-28
86. Kelestimur F. Sheehan's syndrome. Pituitary 2003;6:181-188
87. Stelmach M, O'Day J. Rapid change in visual fields associated with suprasellar lymphocytic hypophysitis. J Clin Neuroophthalmol 1991;11:19-24
88. Flanagan DE, Ibrahim AE, Ellison DW, Armitage M, Gawne-Cain M, Lees PD. Inflammatory hypophysitis - the spectrum of disease. Acta Neurochir (Wien) 2002;144:47-56
89. McCutcheon IE, Oldfield EH. Lymphocytic adenohypophysitis presenting as infertility. Case report. J Neurosurg 1991;74:821-826
90. Horvath E, Vidal S, Syro LV, Kovacs K, Smyth HS, Uribe H. Severe lymphocytic adenohypophysitis with selective disappearance of prolactin cells: a histologic, ultrastructural and immunoelectron microscopic study. Acta Neuropathol (Berl) 2001;101:631-637
91. Miyagi K, Shingaki T, Ito K, et al. Lymphocytic infundibulo-hypophysitis with diabetes insipidus as a new clinical entity: a case report and review of the literature. No Shinkei Geka 1997;25:169-175
92. Ikeda H, Okudaira Y. Spontaneous regression of pituitary mass in temporal association with pregnancy. Neuroradiology 1987;29:488-492
93. Osborn A. Diagnostic Neuroradiology. St. Louis: CV Mosby, 1994
94. Elster AD. Modern imaging of the pituitary. Radiology 1993;187:1-14
95. Ikeda H, Yoshimoto T. Visual disturbances in patients with pituitary adenoma. Acta Neurol Scand 1995;92:157-160
96. Saeki N, Uchino Y, Murai H, et al. MR imaging study of edema-like change along the optic tract in patients with pituitary region tumors. AJNR Am J Neuroradiol 2003; 24:336-342
97. Arita K, Uozumi T, Yano T, et al. MRI visualization of complete bilateral optic nerve involvement by pituitary adenoma: a case report. Neuroradiology 1993;35:549-550
98. Gallucci M, Bozzao A, Splendiani A, Masciocchi C, Passariello R. Wernicke encephalopathy: MR findings in five patients. AJNR Am J Neuroradiol 1990;11:887-892
99. Chung SP, Kim SW, Yoo IS, et al. Magnetic resonance imaging as a diagnostic adjunct to Wernicke encephalopathy in the ED. Am J Emerg Med 2003;21:497-502
100. Togay-Isikay C, Yigit A, Mutluer N. Wernicke's encephalopathy due to hyperemesis gravidarum. Diffusion-weighted imaging abnormalities in Wernicke encephalopathy: reversible cytotoxic edema? An under-recognised condition. Aust N Z J Obstet Gynaecol 2001;41:453-456
101. Chu K, Kang DW, Kim HJ, Lee YS, Park SH. Diffusion-weighted imaging abnormalities in Wernicke encephalopathy: reversible cytotoxic edema. Arch Neurol 2002;59:123-127
102. Confavreux C, Hutchinson M, Hours MM, et al. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in multiple sclerosis group. N Engl J Med 1998;339:285-291
103. Soldan SS, Alavrez Retuerto AI, Sicotte NL, Voskuhl RR. Immune modulation in multiple sclerosis patients treated with pregnancy hormone estriol. J Immunol 2003;171: 6267-6274
104. Sandhu FS, Dillon WP. Spinal epidural abscess: evaluation with contrast-enhanced MR imaging. AJNR Am J Neuroradiol 1991;12:1087-1093
105. Yonekawa Y, Mehdorn HM, Nishikaw M. Spontaneous spinal epidural hematoma during pregnancy. Surg Neurol 1975;3:327-328
106. Osei EK, Faulkner K. Fetal doses from radiological examinations. Br J Radiol 1999;72:773-780